Skip to content

Analysis of the Impact of Female Hormone Levels on the Risk of Metabolic-Related Steatosis and Model Construction

Analysis of the Impact of Female Hormone Levels on the Risk of Metabolic-Related Steatosis and Model Construction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118097
Enrollment
Unknown
Registered
2026-02-02
Start date
2024-08-07
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic associated fatty liver disease

Interventions

Fatty Liver Group:NA

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Female, aged 20-65, met the diagnostic criteria for metabolic associated fatty liver disease; 2. Meet the diagnostic criteria for metabolic syndrome.

Exclusion criteria

Exclusion criteria: 1. Fatty liver due to other causes, such as alcoholic, immune, viral, drug-induced, hereditary, toxic, and, among others, organ lesions; 2. Those who refused to sign an informed consent form; 3. For endocrine hormone disorders have been drug treatment, have been used hypoglycemic drugs, lipid-lowering drugs, antihypertensive drugs;

Design outcomes

Primary

MeasureTime frame
thyroid function (FT3, FT4, TSH) ;estradiol;testosterone;age;

Secondary

MeasureTime frame
Liver function (ALT, AST, GGT, TBIL, DBIL, IBIL);kidney function (Cr, UA, BUN);blood lipids (TG, TCH, LDL, HDL);fasting blood glucose;fasting insulin;

Countries

China

Contacts

Public ContactWang Weiqin

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

wangweiqinjn@163.com+86 531 68616726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026